Quick Takeaways
- Peter Greenleaf has 4 issuer positions tracked on this page.
- Estimated disclosed ownership value: $26,679,005.
- Recent insider filing activity is available below.
- Info
- Insider Ownership
Insider Trading & Ownership of Peter Greenleaf
- Location
- Edmonton
- Summary
- The estimated net worth of Peter Greenleaf is at least $26,679,005 dollars as of 06 Apr 2026. Peter Greenleaf is the Chief Executive Officer, Director of Aurinia Pharmaceuticals Inc. and owns shares of Aurinia Pharmaceuticals Inc. (AUPH) stock worth about $26.15M. Peter Greenleaf is the Director of Pelthos Therapeutics Inc. and owns shares of Pelthos Therapeutics Inc. (PTHS) stock worth about $527.2K.
- Signature
- /s/ Francis Knuettel II, by power of attorney
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Peter Greenleaf and return when a new Insider Trading filing appears.
This tracks SEC filing changes for this page using existing product update flows.
What Changed
- Largest disclosed position: Aurinia Pharmaceuticals Inc. ($26,151,785).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Official SEC Source
Filed on Form 4
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
See Original FilingOwnership of Peter Greenleaf
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| AUPH | Aurinia Pharmaceuticals Inc. | Chief Executive Officer, Director | $26,151,785 | 27 Feb 2026 | ||
| PTHS | Pelthos Therapeutics Inc. | Director | $527,220 | -$16,670 | -3.1% | 02 Apr 2026 |
| ATRS | ANTARES PHARMA, INC. | Director | 24 May 2022 | |||
| BDSI | BIODELIVERY SCIENCES INTERNATIONAL INC | Director | 22 Mar 2022 |
Insider Transactions Reported by Peter Greenleaf:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.